Sign in
4

Changes in Ownership

CNS Pharmaceuticals, Inc. Filed Acc 0001683168-22-001495

Chief Executive Officer acquired 35,000 shares (grant or award)

From the SEC's structured data for this filing

Trades in this filing

Climaco John M · Chief Executive Officer

Table I: Non-derivative

1 line
Date Transaction Shares Price Value Owned after D/I
2022-03-07 Grant or award : show line 1 in the form +35,000 $0.28 $9,835 940,298 D
Loading xslF345X03/ownership.xml…